Specialist pediatric and maternity/obstetrics hospital chain operating across major Indian cities.
Specialist pediatric and maternity/obstetrics hospital chain operating across major Indian cities.
Earns charges for inpatient care, deliveries and specialist outpatient visits, using a hub-and-spoke model in which large hospitals take complex cases referred from smaller clinics nearby. It began in Hyderabad, still its home base, and runs a separate BirthRight by Rainbow brand for maternity.
In one line: India's dedicated children's-hospital operator.
Moat: narrow (brand, process know-how). Focused pediatric specialization builds trust and a referral network that general hospitals lack.
Headquarters: Hyderabad, India · Founded: 1998 · Employees: 6,397
Size Rainbow Childrens Medicare (RAINBOW.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $1.37B, the 505th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹1,258 on 18 Nov 2026.
Performance Over six months the shares fell 6.9%, against -3.8% for the median peer and +3.8% for the India market (cap-weighted) — 10th lowest of 20 in its peer set.
Growth Revenue grew 22.8% over the last twelve months (peer median +8.7%); the operating margin is 22.3% (peer median 9.3%).
Valuation It trades at 40.4× forward earnings against a peer median of 28.9× (8th most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 31% a year for seven years (Req g). Recent delivered growth is +21%, so the hurdle is +9 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 1.3 points above its cost of capital (12.4% WACC).
Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹19.2B | ₹17.0B | ₹15.2B | ₹13.0B | ₹11.7B |
| Revenue growth | — | +12% | +17% | +11% | — |
| Gross profit | ₹7.50B | ₹5.61B | ₹5.04B | ₹4.47B | ₹4.36B |
| EBITDA | ₹5.96B | ₹5.54B | ₹4.99B | ₹4.39B | ₹4.05B |
| Net income | ₹2.92B | ₹2.78B | ₹2.43B | ₹2.17B | ₹2.11B |
| Free cash flow | n/a | ₹1.37B | ₹2.72B | -₹90.7M | ₹2.00B |
| Capital expenditure | n/a | ₹2.16B | ₹1.46B | ₹3.54B | ₹1.41B |
| Total debt | ₹9.68B | ₹8.91B | ₹7.64B | ₹7.65B | ₹5.70B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Rainbow Childrens Medicare RAINBOW.NS | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% |
| Global Health MEDANTA.NS | $4.13B | +16% | +26% | 17% | 50.4× | n/a |
| Apollo Hospitals Enterprise APOLLOHOSP.NS | $13.6B | +10% | +19% | 12% | 51.0× | 33.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | RAINBOW.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.8% | +1.2% | 9th highest of 20 |
| 6-month return | -6.9% | -3.8% | 10th lowest of 20 |
| Distance from 52-week high | -21.9% | -22.2% | 10th highest of 21 |
| Revenue growth (TTM) | +22.8% | +8.7% | 4th highest of 21 |
| Operating margin | 22.3% | 9.3% | highest of 21 |
| Forward P/E | 40.4× | 28.9× | 8th most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 30.7% | 11.8% | most demanding of 15 |
| Growth delivered (Del g) | +21.2% | +9.5% | highest of 15 |
| Hurdle (Req g minus delivered) | +9.4 pp | +1.2 pp | 5th most demanding of 15 |
| ROIC minus cost of capital | +1.3 pp | -2.7 pp | 5th highest of 21 |
| EV / EBITDA | 22.5× | 14.9× | 6th most expensive of 16 |
| Net debt / EBITDA | 1.0× | 3.0× | 6th least indebted of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 27.1× | -2.7% | +6.1% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 14.6× | 14.2% | +6.9% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 49.4× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | n/a | 6.1% | +6.0% |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | n/a | n/a | n/a |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 88.8× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | n/a | 21.2% | +11.8% |
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% | +8.7% |
| Brookdale Senior Living BKD | United States | $2.06B | -36% | -8% | 6% | 482.6× | 19.3% | -1.4% |